Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. As a leader in muscle biology and the mechanics of muscle performance, we are developing small molecule drug candidates specifically engineered to impact muscle function and contractility. Proud to be a San Francisco Business Times Best Place to Work in 2021 and 2022, a Great Place to Work-Certified company in 2022 and a part of Fortune's Best Workplaces in the Bay Area in 2022 and Fortune's Best Workplaces in BioPharma in 2022.
Looking for a particular Cytokinetics employee's phone or email?
Cytokinetics Questions
The Cytokinetics annual revenue was $18.5 million in 2026.
Robert Blum is the President and CEO of Cytokinetics.
626 people are employed at Cytokinetics.
Cytokinetics is based in South San Francisco, California.
The NAICS codes for Cytokinetics are [32541, 3254, 325, 32].
The SIC codes for Cytokinetics are [28, 283].
Top Cytokinetics Employees
-
Robert Blum
President and CEO at Cytokinetics
South San Francisco, CA, US24 -
Ching Jaw
Chief Financial Officer at Cytokinetics
California, United States15 -
Imola Fodor
VP of Biometrics at Cytokinetics
South San Francisco, CA, US23 -
Kari Loeser
Vice President, Chief Compliance Officer at Cytokinetics
South San Francisco, CA, US35+ -
Daniel Jacoby
Vice President Clinical Research at Cytokinetics
South San Francisco, CA, US22 -
Elisabeth Schnieders
Senior Vice President, Business Development at Cytokinetics
South San Francisco, CA, US25 -
Ajay Chawla
Vice President-Head of Research at Cytokinetics
South San Francisco, CA, US12 -
Stuart Kupfer
Chief Medical Officer at Cytokinetics
Chicago, IL, US15+
Related Companies
